Ioannis Vardakas
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.
Journal: Neurology
Published: July 02, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).
Journal: European journal of neurology
Published: August 12, 2025
Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.
Journal: Biomedicines
Published: July 09, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study.
Journal: Therapeutic advances in neurological disorders
Published: July 01, 2025
Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust.
Journal: Brain sciences
Published: June 23, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 15, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 15, 2025
Plasma Exchange vs. Immunoadsorption: Effects on Immunological Markers and Predictive Value in Steroid-Refractory MS Attacks.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 17, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 19, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Journal: Journal of neurology
Published: July 08, 2024
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid-refractory multiple sclerosis relapses.
Journal: European journal of neurology
Published: February 29, 2024
Last Updated: 09/26/2026